<code id='9929D7D63A'></code><style id='9929D7D63A'></style>
    • <acronym id='9929D7D63A'></acronym>
      <center id='9929D7D63A'><center id='9929D7D63A'><tfoot id='9929D7D63A'></tfoot></center><abbr id='9929D7D63A'><dir id='9929D7D63A'><tfoot id='9929D7D63A'></tfoot><noframes id='9929D7D63A'>

    • <optgroup id='9929D7D63A'><strike id='9929D7D63A'><sup id='9929D7D63A'></sup></strike><code id='9929D7D63A'></code></optgroup>
        1. <b id='9929D7D63A'><label id='9929D7D63A'><select id='9929D7D63A'><dt id='9929D7D63A'><span id='9929D7D63A'></span></dt></select></label></b><u id='9929D7D63A'></u>
          <i id='9929D7D63A'><strike id='9929D7D63A'><tt id='9929D7D63A'><pre id='9929D7D63A'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:5369
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

          1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

          read more
          Inari Medical to buy amputation prevention company LimFlow
          Inari Medical to buy amputation prevention company LimFlow

          Inariwillpay$250millionupfrontand$165moredependingonLimFlow’scommercialsuccess.DavidGregory&Debb

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          FDA's Pazdur wants cancer trials to range beyond China alone

          RichardPazdur,right,alsospokeabouttheFDA'suseofacceleratedapproval.MeganBearderPhotographyCHICAGO— T